EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Drug Removal by Hemoadsorption

Ilona Lemagnen, Céline Monard, Maxime Palluau, Layla Bergamaschi, Taku Furukawa, Rinaldo Bellomo, Antoine Schneider

Blood Purification · 21.04.2025 · 55 (6-7) · 366-378

DOI: 10.1159/000545804 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Blood Purification, online erschienen am 21.04.2025. Verfasst von Ilona Lemagnen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Adult Intensive Care Unit, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. Hauptthemen laut MEDLINE: Hemoperfusion. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: There is growing interest in hemoadsorption (HA) therapies in critically ill patients although their precise indications remain to be established. Several devices are available on the market with heterogeneous properties and capabilities. Summary: Due to the nonspecific removal associated with most HA techniques, concerns have been raised on their unintended removal of drugs such as anti-infectives in sepsis. On the other hand, drug removal might be beneficial in certain situations for instance antithrombotic medications in patients requiring emergency surgery or in case of accidental or self-induced intoxication. In this review, we summarize available in vitro, in vivo, and clinical studies reporting on the influence of various HA techniques on drugs pharmacokinetics. Key Message: We conclude that further studies should aim at providing drug dosing recommendations during HA and confirm its safety, efficacy, and practicalities when used for intoxications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemoperfusionHumansAdsorptionCritical IllnessFibrinolytic AgentsAnimals

Stichwörter der Autor:innen

AntibioticsAntithromboticDrugsHemoadsorptionIntoxicationRemoval

Substanzen

Fibrinolytic Agents

Autor:innen und Institutionen

  • Adult Intensive Care Unit, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
  • Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
  • Departement of Cardiovascular Surgery, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
  • Preclinical Critical Care Unit, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, Victoria, Australia.
  • Department of Critical Care, Melbourne Medical School, University of Melbourne, Melbourne, Victoria, Australia.
  • Adult Intensive Care Unit, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland, antoine.schneider@chuv.ch.

Zitieren

APA

Lemagnen, I., Monard, C., Palluau, M., Bergamaschi, L., Furukawa, T., Bellomo, R., & Schneider, A. (2025). Drug Removal by Hemoadsorption. Blood Purification, 55(6-7), 366-378. https://doi.org/10.1159/000545804

Vancouver

Lemagnen I, Monard C, Palluau M, Bergamaschi L, Furukawa T, Bellomo R, et al. Drug Removal by Hemoadsorption. Blood Purification. 2025;55(6-7):366-378. doi:10.1159/000545804

BibTeX
@article{Lemagnen2025,
  author = {Lemagnen, Ilona and Monard, Céline and Palluau, Maxime and Bergamaschi, Layla and Furukawa, Taku and Bellomo, Rinaldo and Schneider, Antoine},
  title = {Drug Removal by Hemoadsorption},
  journal = {Blood Purification},
  year = {2025},
  volume = {55},
  number = {6-7},
  pages = {366--378},
  doi = {10.1159/000545804}
}
Kostenlos starten →